Related Experiment Video
Updated: Apr 23, 2026
07:24
A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
1.4K
Sickle cell solubility test: evaluation of an in-house method
British Journal of Biomedical Science
|October 1, 2014
Summary
An in-house sickle cell solubility test (SCT) demonstrates excellent performance, achieving 100% sensitivity and specificity. This reliable method accurately detects low levels of sickle haemoglobin (Hb S) and resists common interfering substances.
Area of Science:
- Clinical Chemistry
- Haematology
- Diagnostic Assay Development
Background:
- Sickle cell disease diagnosis relies on accurate detection of abnormal haemoglobin.
- Existing diagnostic methods vary in performance and cost-effectiveness.
- Standardization and validation of in-house diagnostic tests are crucial.
Purpose of the Study:
- To evaluate the performance of an in-house sickle cell solubility test (SCT).
- To compare the in-house SCT against published data on other methods, including commercial kits.
- To assess potential interferences affecting the SCT's accuracy.
Main Methods:
- A total of 1030 patient samples were tested using the in-house SCT.
- Samples were subsequently confirmed using high-performance liquid chromatography (HPLC).
- Interference testing included varying haemoglobin levels, Hb F, Hb S, lipaemia, icterus, and haemolysis index.
Main Results:
- The in-house SCT showed 100% sensitivity and 100% specificity.
- It accurately detected low levels of sickle haemoglobin (Hb S) down to 12.1%.
- The test demonstrated robustness against common interfering substances like lipaemia.
Conclusions:
- The in-house SCT exhibits excellent diagnostic performance, comparable to or exceeding commercial kits.
- The method is reliable for detecting sickle haemoglobin, even at low concentrations.
- In-house developed diagnostic tests can yield highly dependable results for sickle cell screening.
